Villanova Investment Management’s Integra LifeSciences IART Stock Holding History

Villanova Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-82,827	Closed	-$1.03M	–	58
2025 Q4	$1.03M	Sell	82,827 -629	-0.8%	-$8.36K	0.73%	55
2025 Q3	$1.2M	Buy	83,456 +22,480	+37%	+$308K	0.83%	53
2025 Q2	$748K	Buy	60,976 +42,750	+235%	+$621K	0.77%	53
2025 Q1	$1.15M	Sell	18,226 -24,998	-58%	-$588K	1.14%	44
2024 Q4	$980K	Buy	43,224 +4,217	+11%	+$92K	0.87%	50
2024 Q3	$709K	Sell	39,007 -10,384	-21%	-$241K	0.76%	52
2024 Q2	$1.44M	Buy	+49,391	New	+$1.46M	1.53%	31

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Villanova Investment Management's IART Position: Q1 2026 in Review

Villanova Investment Management sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 82,827 shares — an estimated $1.03M sold.

Villanova Investment Management first reported a position in IART in Q2 2024 and held it in 7 quarters. The position peaked at $1.44M in Q2 2024. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Villanova Investment Management reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Villanova Investment Management sold 82,827 Integra LifeSciences shares in Q1 2026, an estimated $1.03M.
Villanova Investment Management first reported a position in Integra LifeSciences in Q2 2024 and held it in 7 quarters.
Villanova Investment Management's Integra LifeSciences position peaked at $1.44M in Q2 2024.
202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Villanova Investment Management's 13F filing for Q1 2026, filed 8 May 2026.